메뉴 건너뛰기




Volumn , Issue , 2012, Pages 502-521

Heparin neutralization

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84970979578     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter
Times cited : (3)

References (106)
  • 1
    • 0025935153 scopus 로고
    • Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. Am J Clin Pathol 1991;96:394-397.Hunt AJ, Gray GS, Myers JA, et al. Heparin neutralization by recombinant human PF4
    • Brady J, Riccio JA, Yumen OH, et al. Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. Am J Clin Pathol 1991;96:394-397.Hunt AJ, Gray GS, Myers JA, et al. Heparin neutralization by recombinant human PF4 in vitro. FASEB J 1990;4:A1991(abst).
    • (1990) in vitro. FASEB J , vol.4 , pp. A1991
    • Brady, J.1    Riccio, J.A.2    Yumen, O.H.3
  • 3
    • 0019949388 scopus 로고
    • Protamine as an inhibitor of angiogenesis
    • Taylor S, Folkman J. Protamine as an inhibitor of angiogenesis. Nature 1982;297:307-312.
    • (1982) Nature , vol.297 , pp. 307-312
    • Taylor, S.1    Folkman, J.2
  • 4
    • 0014326144 scopus 로고
    • Clinical trial of protamine in the treatment of malignant diseases
    • Wright JEC. Clinical trial of protamine in the treatment of malignant diseases. Br J Cancer 1968;22:415-421.
    • (1968) Br J Cancer , vol.22 , pp. 415-421
    • Wright, J.E.C.1
  • 5
    • 0000730965 scopus 로고
    • Studies on the chemistry of blood coagulation
    • Chargaff E, Olson KB. Studies on the chemistry of blood coagulation. J Biol Chem 1937;122:153-167.
    • (1937) J Biol Chem , vol.122 , pp. 153-167
    • Chargaff, E.1    Olson, K.B.2
  • 6
    • 0009490902 scopus 로고
    • Neutralization of heparin in vivo with protamine:a simple method of estimating the required dose
    • Perkins HA, Osborn JJ, Hurt R, et al. Neutralization of heparin in vivo with protamine:a simple method of estimating the required dose. J Lab Clin Med 1956;48:223-226.
    • (1956) J Lab Clin Med , vol.48 , pp. 223-226
    • Perkins, H.A.1    Osborn, J.J.2    Hurt, R.3
  • 7
    • 0015172341 scopus 로고
    • Is protamine a clinically significant anticoagulant? A negative answer
    • Ellison N, Ominsky AJ, Wollman H. Is protamine a clinically significant anticoagulant? A negative answer. Anesthesiology 1971;35:621-629.
    • (1971) Anesthesiology , vol.35 , pp. 621-629
    • Ellison, N.1    Ominsky, A.J.2    Wollman, H.3
  • 8
    • 0024806880 scopus 로고
    • Activated partial thromboplastin time-protamine dose in the presence and absence of heparin
    • Inagaki M, Goto K, Katayama H, et al. Activated partial thromboplastin time-protamine dose in the presence and absence of heparin. J Cardiothorac Anesth 1989;3:734-736.
    • (1989) J Cardiothorac Anesth , vol.3 , pp. 734-736
    • Inagaki, M.1    Goto, K.2    Katayama, H.3
  • 9
    • 0017885711 scopus 로고
    • Platelet aggregation following heparin and protamine administration
    • Ellison N, Edmunds LH, Colman RW. Platelet aggregation following heparin and protamine administration. Anesthesiology 1978;48:65-68.
    • (1978) Anesthesiology , vol.48 , pp. 65-68
    • Ellison, N.1    Edmunds, L.H.2    Colman, R.W.3
  • 10
    • 0022363464 scopus 로고
    • Hemostasis changes during cardiopulmonary bypass surgery
    • Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985;11:281-292.
    • (1985) Semin Thromb Hemost , vol.11 , pp. 281-292
    • Mammen, E.F.1    Koets, M.H.2    Washington, B.C.3
  • 11
    • 0017230999 scopus 로고
    • Successful use of a reduced dose of protamine after cardiopulmonary bypass
    • Guffin AV, Dunbar RW, Kaplan JA, et al. Successful use of a reduced dose of protamine after cardiopulmonary bypass. Anesth Analg 1976;55:110-113.
    • (1976) Anesth Analg , vol.55 , pp. 110-113
    • Guffin, A.V.1    Dunbar, R.W.2    Kaplan, J.A.3
  • 13
    • 0023741209 scopus 로고
    • Anticoagulant effects of protamine sulfate in the canine model
    • Kresowik tF, Wakefield TW, Fessler RD, et al. Anticoagulant effects of protamine sulfate in the canine model. J Surg Res 1988;45:8-14.
    • (1988) J Surg Res , vol.45 , pp. 8-14
    • Kresowik, T.F.1    Wakefield, T.W.2    Fessler, R.D.3
  • 14
    • 0016808488 scopus 로고
    • Heparin therapy during extracorporeal circulation, I. Problems inherent in existing heparin protocols
    • Bull BS, Korpman RA, Huse WM, et al. Heparin therapy during extracorporeal circulation, I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975;69:674-684.
    • (1975) J Thorac Cardiovasc Surg , vol.69 , pp. 674-684
    • Bull, B.S.1    Korpman, R.A.2    Huse, W.M.3
  • 15
    • 0031984680 scopus 로고    scopus 로고
    • Adverse events after protamine administration in patients undergoing cardiopulmonary bypass:risks and predictors of underreporting
    • Kimmel SE, Sekeres MA, Berlin JA, et al. Adverse events after protamine administration in patients undergoing cardiopulmonary bypass:risks and predictors of underreporting. J Clin Epidemiol 1998;51:1-10.
    • (1998) J Clin Epidemiol , vol.51 , pp. 1-10
    • Kimmel, S.E.1    Sekeres, M.A.2    Berlin, J.A.3
  • 16
    • 0000685584 scopus 로고
    • The neutralization of heparin by protamine in extracorporeal circulation
    • Hurt R, Perkins HA, Osborn JJ, et al. The neutralization of heparin by protamine in extracorporeal circulation. J Thorac Surg 1956;32:612-619.
    • (1956) J Thorac Surg , vol.32 , pp. 612-619
    • Hurt, R.1    Perkins, H.A.2    Osborn, J.J.3
  • 17
    • 0014004037 scopus 로고
    • Activated coagulation time of whole blood
    • Hattersley PG. Activated coagulation time of whole blood. JAMA 1966;196:150-154.
    • (1966) JAMA , vol.196 , pp. 150-154
    • Hattersley, P.G.1
  • 18
    • 0018917017 scopus 로고
    • Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass
    • Akl BF, Vargas GM, Neal J, et al. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1980;79:97-102.
    • (1980) J Thorac Cardiovasc Surg , vol.79 , pp. 97-102
    • Akl, B.F.1    Vargas, G.M.2    Neal, J.3
  • 19
    • 0016737841 scopus 로고
    • Heparin therapy during extracorporeal circulation, II. The use of a dose-response curve to individualize heparin and protamine dosage
    • Bull BS, Huse WM, Brauer FS, et al. Heparin therapy during extracorporeal circulation, II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975;69:685-689.
    • (1975) J Thorac Cardiovasc Surg , vol.69 , pp. 685-689
    • Bull, B.S.1    Huse, W.M.2    Brauer, F.S.3
  • 21
    • 0019421426 scopus 로고
    • Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass
    • Culliford AT, Gitel SN, Starr N, et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg 1981;193:105-111.
    • (1981) Ann Surg , vol.193 , pp. 105-111
    • Culliford, A.T.1    Gitel, S.N.2    Starr, N.3
  • 22
    • 0015576421 scopus 로고
    • Plasma heparin:a unique, practical, submicrogram-sensitive assay
    • Yin ET, Wessler S, Butler JV. Plasma heparin:a unique, practical, submicrogram-sensitive assay. J Lab Clin Med 1973;81:298-310.
    • (1973) J Lab Clin Med , vol.81 , pp. 298-310
    • Yin, E.T.1    Wessler, S.2    Butler, J.V.3
  • 23
    • 0004122757 scopus 로고
    • Plasma heparin concentration in extracorporeal circulation
    • Senning A. Plasma heparin concentration in extracorporeal circulation. Acta ChirScand 1959;117:55-59.
    • (1959) Acta ChirScand , vol.117 , pp. 55-59
    • Senning, A.1
  • 24
    • 0029950069 scopus 로고    scopus 로고
    • A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor
    • Wahr JA, Yun JH, Yang VC, et al. A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor. J Cardiothorac Vasc Anesth 1996;10:447-450.
    • (1996) J Cardiothorac Vasc Anesth , vol.10 , pp. 447-450
    • Wahr, J.A.1    Yun, J.H.2    Yang, V.C.3
  • 25
    • 0030972451 scopus 로고    scopus 로고
    • Evaluation of a new protamine titration method to assay heparin in whole blood and plasma
    • Schleuter AJ, Pennell BJ, Olson JD. Evaluation of a new protamine titration method to assay heparin in whole blood and plasma. Am J Clin Pathol 1997;107:511-520.
    • (1997) Am J Clin Pathol , vol.107 , pp. 511-520
    • Schleuter, A.J.1    Pennell, B.J.2    Olson, J.D.3
  • 26
    • 78651027120 scopus 로고
    • A protamine titration as an indication of a clotting defect in certain hemorrhagic states
    • Allen JG, Moulder PV, Elghammer RM, et al. A protamine titration as an indication of a clotting defect in certain hemorrhagic states. JLab Clin Med 1949;34:473-476.
    • (1949) JLab Clin Med , vol.34 , pp. 473-476
    • Allen, J.G.1    Moulder, P.V.2    Elghammer, R.M.3
  • 27
    • 0014012893 scopus 로고
    • De-heparinisation of blood after cardiopulmonary bypass
    • Hawksley M. De-heparinisation of blood after cardiopulmonary bypass. Lancet 1966;1:563-565.
    • (1966) Lancet , vol.1 , pp. 563-565
    • Hawksley, M.1
  • 28
    • 0031918371 scopus 로고    scopus 로고
    • Heparin and protamine titration do not improve hemostasis in cardiac surgical patients
    • Shore-Lesserson L, Reich DL, DePerio M. Heparin and protamine titration do not improve hemostasis in cardiac surgical patients. Can J Anaesth 1998;45:10-18.
    • (1998) Can J Anaesth , vol.45 , pp. 10-18
    • Shore-Lesserson, L.1    Reich, D.L.2    DePerio, M.3
  • 29
    • 0029075636 scopus 로고
    • Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations
    • Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg 1995;110:36-45.
    • (1995) J Thorac Cardiovasc Surg , vol.110 , pp. 36-45
    • Jobes, D.R.1    Aitken, G.L.2    Shaffer, G.W.3
  • 30
    • 0029862772 scopus 로고    scopus 로고
    • Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin-and protamine-related hemodynamic effects
    • Kanbak M, Kahraman S, Celebioglu B, et al. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin-and protamine-related hemodynamic effects. Anaesth Intensive Care 1996;15:559-563.
    • (1996) Anaesth Intensive Care , vol.15 , pp. 559-563
    • Kanbak, M.1    Kahraman, S.2    Celebioglu, B.3
  • 31
    • 0021215631 scopus 로고
    • Successful cardiopulmonary bypass in diabetics with anaphylactoid reactions to protamine
    • Walker WS, Reid KG, Hider CF, et al. Successful cardiopulmonary bypass in diabetics with anaphylactoid reactions to protamine. Br Heart J 1984;52:112-114.
    • (1984) Br Heart J , vol.52 , pp. 112-114
    • Walker, W.S.1    Reid, K.G.2    Hider, C.F.3
  • 32
    • 84970974542 scopus 로고
    • Heparin neutralization by protamine and platelet factor 4 in the rat
    • Cook JJ, Schaffer LH, Niewiarowski S, et al. Heparin neutralization by protamine and platelet factor 4 in the rat. FASEB J 1990;4:A1234(abst).
    • (1990) FASEB J , vol.4 , pp. A1234
    • Cook, J.J.1    Schaffer, L.H.2    Niewiarowski, S.3
  • 33
    • 0026540769 scopus 로고
    • Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without the adverse effects of heparin-protamine complexes
    • Cook JJ, Niewiarowski S, Yan Z, et al. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without the adverse effects of heparin-protamine complexes. Circulation 1992;85:1102-1109.
    • (1992) Circulation , vol.85 , pp. 1102-1109
    • Cook, J.J.1    Niewiarowski, S.2    Yan, Z.3
  • 34
    • 10244224049 scopus 로고    scopus 로고
    • Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans
    • Dehmer GJ, Lange RA, Tate DA, et al. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans. Circulation 1996;94(Suppl):II347-II352.
    • (1996) Circulation , vol.94 , pp. II347-II352
    • Dehmer, G.J.1    Lange, R.A.2    Tate, D.A.3
  • 35
    • 0028869645 scopus 로고
    • Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb
    • Kurrek M, Winkler M, Robinson DR, et al. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. Anesthesiology 1995;82:183-188.
    • (1995) Anesthesiology , vol.82 , pp. 183-188
    • Kurrek, M.1    Winkler, M.2    Robinson, D.R.3
  • 36
    • 0028901687 scopus 로고
    • Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass
    • Bernabei A, Gikakis N, Maione TE, et al. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;109:765-771.
    • (1995) J Thorac Cardiovasc Surg , vol.109 , pp. 765-771
    • Bernabei, A.1    Gikakis, N.2    Maione, T.E.3
  • 37
    • 3843146087 scopus 로고    scopus 로고
    • Recombinant platelet factor 4 for heparin neutralization
    • Mixon TA, Dehmer GJ. Recombinant platelet factor 4 for heparin neutralization. Semin Thromb Hemost 2004;30(3):369-377.
    • (2004) Semin Thromb Hemost , vol.30 , Issue.3 , pp. 369-377
    • Mixon, T.A.1    Dehmer, G.J.2
  • 38
    • 0029041879 scopus 로고
    • Effective and less toxic reversal of low-molecular-weight heparin anticoagulation by a designer variant of protamine
    • Wakefield TW, Andrews PC, Wrobleski SK, et al. Effective and less toxic reversal of low-molecular-weight heparin anticoagulation by a designer variant of protamine. JVasc Surg 1995;21:839-849.
    • (1995) JVasc Surg , vol.21 , pp. 839-849
    • Wakefield, T.W.1    Andrews, P.C.2    Wrobleski, S.K.3
  • 39
    • 0030007549 scopus 로고    scopus 로고
    • A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation
    • Wakefield TW, Andrews PC, Wrobleski SK, et al. A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation. J Surg Res 1996;63:280-286.
    • (1996) J Surg Res , vol.63 , pp. 280-286
    • Wakefield, T.W.1    Andrews, P.C.2    Wrobleski, S.K.3
  • 40
    • 0019865920 scopus 로고
    • Studies on the neutralizing mechanism of anti-thrombin activity of protamine
    • Okajima Y, Kanayama S, Maeda Y, et al. Studies on the neutralizing mechanism of anti-thrombin activity of protamine. Thromb Res 1981;24:21-29.
    • (1981) Thromb Res , vol.24 , pp. 21-29
    • Okajima, Y.1    Kanayama, S.2    Maeda, Y.3
  • 41
    • 0014673113 scopus 로고
    • Antigenicity:some molecular aspects
    • Sela M. Antigenicity:some molecular aspects. Science 1969;166:1365-1374.
    • (1969) Science , vol.166 , pp. 1365-1374
    • Sela, M.1
  • 42
    • 0033119594 scopus 로고    scopus 로고
    • Low molecular weight protamine:a potential nontoxic heparin antagonist
    • Byun Y, Singh VK, et al. Low molecular weight protamine:a potential nontoxic heparin antagonist. Thromb Res 1999;94:53-61.
    • (1999) Thromb Res , vol.94 , pp. 53-61
    • Byun, Y.1    Singh, V.K.2
  • 43
    • 0029811173 scopus 로고    scopus 로고
    • Heparinase I (neutralase) reversal of systemic anticoagulation
    • Michelson LG, Kikura M, Levy JH, et al. Heparinase I (neutralase) reversal of systemic anticoagulation. Anesthesiology 1996;85:339-346.
    • (1996) Anesthesiology , vol.85 , pp. 339-346
    • Michelson, L.G.1    Kikura, M.2    Levy, J.H.3
  • 44
    • 0030948890 scopus 로고    scopus 로고
    • The effects of heparinase 1 and protamine on platelet reactivity
    • Ammar T, Fisher CF. The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology 1997;6:12-16.
    • (1997) Anesthesiology , vol.6 , pp. 12-16
    • Ammar, T.1    Fisher, C.F.2
  • 45
    • 0035204762 scopus 로고    scopus 로고
    • A dose-determining trial of heparinase-I for heparin neutralization in coronary artery surgery
    • Heres EK, Horrow JC, Gravlee GP, et al. A dose-determining trial of heparinase-I for heparin neutralization in coronary artery surgery. Anesth Analg 2001;93(6):1446-1452.
    • (2001) Anesth Analg , vol.93 , Issue.6 , pp. 1446-1452
    • Heres, E.K.1    Horrow, J.C.2    Gravlee, G.P.3
  • 46
    • 23044475017 scopus 로고    scopus 로고
    • Members of the Global Perioperative Research Organization. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass
    • Stafford-Smith, M, Lefrak, EA, Qazi, AG, et al. Members of the Global Perioperative Research Organization. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass. Anesthesiology 2005;103:229-240.
    • (2005) Anesthesiology , vol.103 , pp. 229-240
    • Stafford-Smith, M.1    Lefrak, E.A.2    Qazi, A.G.3
  • 47
    • 0030956697 scopus 로고    scopus 로고
    • The use of heparin removal devices:a valid alternative to protamine
    • Hendrikx M, Leuvens V, Vandezarde E, et al. The use of heparin removal devices:a valid alternative to protamine. Int J Artif Organs 1997;20:166-174.
    • (1997) Int J Artif Organs , vol.20 , pp. 166-174
    • Hendrikx, M.1    Leuvens, V.2    Vandezarde, E.3
  • 48
    • 0021022005 scopus 로고
    • The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-297.Lowenstein E, Johnston WE, Lappas DG, et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.
    • Yang VC, Port FK, Kim JS, et al. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-297.Lowenstein E, Johnston WE, Lappas DG, et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology 1983;59:470-473.
    • (1983) Anesthesiology , vol.59 , pp. 470-473
    • Yang, V.C.1    Port, F.K.2    Kim, J.S.3
  • 50
    • 84882714678 scopus 로고    scopus 로고
    • Aspirin prevents protamine-induced pulmonary hypertension
    • Comunale ME, Haering JM, Robertson LK, et al. Aspirin prevents protamine-induced pulmonary hypertension. Anesth Analg 1997;84:S66.
    • (1997) Anesth Analg , vol.84 , pp. S66
    • Comunale, M.E.1    Haering, J.M.2    Robertson, L.K.3
  • 51
    • 0025081282 scopus 로고
    • Neutralization of heparin by protamine, time for a change
    • Schapira M, Christman BW. Neutralization of heparin by protamine, time for a change? Circulation 1990;82:1887-1879.
    • (1990) Circulation , vol.82 , pp. 1879-1887
    • Schapira, M.1    Christman, B.W.2
  • 53
    • 0020080987 scopus 로고
    • Histamine release during morphine and fentanyl anesthesia
    • Rosow CE, Moss J, Philbin DM, et al. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 1982;56:93-96.
    • (1982) Anesthesiology , vol.56 , pp. 93-96
    • Rosow, C.E.1    Moss, J.2    Philbin, D.M.3
  • 54
    • 0014229689 scopus 로고
    • Interrelation between different types of cells. II. Histamine release for the mast cells of various species by cationic polypeptides of polymorphonuclear leukocytes, lysosomes and other cationic compounds
    • Keller R. Interrelation between different types of cells. II. Histamine release for the mast cells of various species by cationic polypeptides of polymorphonuclear leukocytes, lysosomes and other cationic compounds. Int Arch Allergy Appl Immunol 1968;34:139-144.
    • (1968) Int Arch Allergy Appl Immunol , vol.34 , pp. 139-144
    • Keller, R.1
  • 55
    • 0021158776 scopus 로고
    • Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs
    • Stoelting RK, Henry DP, Verbur KM, et al. Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs. Can Anaesth Soc J 1984;31:534-540.
    • (1984) Can Anaesth Soc J , vol.31 , pp. 534-540
    • Stoelting, R.K.1    Henry, D.P.2    Verbur, K.M.3
  • 56
    • 0024589323 scopus 로고
    • The effect of histamine-receptor blockade on the hemodynamic responses to protamine
    • Parsons RS, Mohandas K. The effect of histamine-receptor blockade on the hemodynamic responses to protamine. J Cardiothorac Anesth 1989;3:37-43.
    • (1989) J Cardiothorac Anesth , vol.3 , pp. 37-43
    • Parsons, R.S.1    Mohandas, K.2
  • 58
    • 0020024770 scopus 로고
    • Further studies on the myocardial metabolic effect of protamine sulfate following cardiopulmonary bypass
    • Sethna D, Gray R, Bussell J, et al. Further studies on the myocardial metabolic effect of protamine sulfate following cardiopulmonary bypass. Anesth Analg 1982;61:476-477.
    • (1982) Anesth Analg , vol.61 , pp. 476-477
    • Sethna, D.1    Gray, R.2    Bussell, J.3
  • 60
    • 0020638287 scopus 로고
    • Hemodynamic changes during protamine administration
    • Michaels IAL, Barash PG. Hemodynamic changes during protamine administration. Anesth Analg 1983;62:831-835.
    • (1983) Anesth Analg , vol.62 , pp. 831-835
    • Michaels, I.A.L.1    Barash, P.G.2
  • 61
    • 0020060604 scopus 로고
    • Effects of protamine sulfate on myocardial oxygen supply and demand in patients following cardiopulmonary bypass
    • Sethna DH, Moffitt E, Gray RJ, et al. Effects of protamine sulfate on myocardial oxygen supply and demand in patients following cardiopulmonary bypass. Anesth Analg 1982;61:157-251.
    • (1982) Anesth Analg , vol.61 , pp. 157-251
    • Sethna, D.H.1    Moffitt, E.2    Gray, R.J.3
  • 62
    • 0021829399 scopus 로고
    • Protamine-induced fatal anaphylaxis, prevalence of antiprotamine immunoglobin E antibody
    • Sharath MD, Metzger WJ, Richerson HB, et al. Protamine-induced fatal anaphylaxis, prevalence of antiprotamine immunoglobin E antibody. J Thorac Cardiovasc Surg 1985;90:86-90.
    • (1985) J Thorac Cardiovasc Surg , vol.90 , pp. 86-90
    • Sharath, M.D.1    Metzger, W.J.2    Richerson, H.B.3
  • 63
    • 0022531687 scopus 로고
    • Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes
    • Levy JH, Zaidan JR, Faraj B. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. Anesth Analg 1986;65:739-742.
    • (1986) Anesth Analg , vol.65 , pp. 739-742
    • Levy, J.H.1    Zaidan, J.R.2    Faraj, B.3
  • 64
    • 0024598118 scopus 로고
    • Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine
    • Weiss ME, Nyhan D, Peng Z, et al. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 1989;320:886-892.
    • (1989) N Engl J Med , vol.320 , pp. 886-892
    • Weiss, M.E.1    Nyhan, D.2    Peng, Z.3
  • 65
    • 0019826927 scopus 로고
    • An anaphylactic reaction to protamine in a patient allergic to fish
    • Knape JTA, Schuller JL, De Haan P, et al. An anaphylactic reaction to protamine in a patient allergic to fish. Anesthesiology 1981;55:315-325.
    • (1981) Anesthesiology , vol.55 , pp. 315-325
    • Knape, J.T.A.1    Schuller, J.L.2    De Haan, P.3
  • 66
    • 0017307631 scopus 로고
    • Protamine sulfate and fish allergy [Letter]
    • Caplan SN, Berkman EM. Protamine sulfate and fish allergy [Letter]. N Engl J Med 1976;295:172.
    • (1976) N Engl J Med , vol.295 , pp. 172
    • Caplan, S.N.1    Berkman, E.M.2
  • 67
    • 0016750489 scopus 로고
    • Auto-immunity to sperm antigens in vasectomized men
    • Samuel T, Kolk AHJ, Rumke P, et al. Auto-immunity to sperm antigens in vasectomized men. Clin Exp Immunol 1975;21:65-74.
    • (1975) Clin Exp Immunol , vol.21 , pp. 65-74
    • Samuel, T.1    Kolk, A.H.J.2    Rumke, P.3
  • 69
    • 0021060065 scopus 로고
    • Classical pathway activation during an adverse response to protamine sulfate
    • Best N, Teisner B, Grudzinkas JG, et al. Classical pathway activation during an adverse response to protamine sulfate. Br J Anaesth 1983;55:1149-1153.
    • (1983) Br J Anaesth , vol.55 , pp. 1149-1153
    • Best, N.1    Teisner, B.2    Grudzinkas, J.G.3
  • 70
    • 0016435864 scopus 로고
    • Complement activation by interaction of polyanions and polycations, I. Heparin-protamine induced consumption of complement
    • Rent R, Ertel N, Eisenstein R, et al. Complement activation by interaction of polyanions and polycations, I. Heparin-protamine induced consumption of complement. J Immunol 1975;114:120-115.
    • (1975) J Immunol , vol.114 , pp. 115-120
    • Rent, R.1    Ertel, N.2    Eisenstein, R.3
  • 71
    • 0022627564 scopus 로고
    • Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state
    • Kirklin JK, Chenoweth DE, Naftel DC, et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 1986;41:193-199.
    • (1986) Ann Thorac Surg , vol.41 , pp. 193-199
    • Kirklin, J.K.1    Chenoweth, D.E.2    Naftel, D.C.3
  • 72
    • 0022339265 scopus 로고
    • Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass
    • Cavarocchi NC, Schaff HV, Orszulak TA, et al. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery 1985;98:525-530.
    • (1985) Surgery , vol.98 , pp. 525-530
    • Cavarocchi, N.C.1    Schaff, H.V.2    Orszulak, T.A.3
  • 73
    • 0016612576 scopus 로고
    • Complement-mediated release of histamine from human leukocytes
    • Grant JA, Dupree E, Goldman AS, et al. Complement-mediated release of histamine from human leukocytes. J Immunol 1975;114:1101-1106.
    • (1975) J Immunol , vol.114 , pp. 1101-1106
    • Grant, J.A.1    Dupree, E.2    Goldman, A.S.3
  • 74
    • 0024589228 scopus 로고
    • Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins
    • Tan F, Jackman H, Skidgel RA, et al. Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins. Anesthesiology 1989;70:267-275.
    • (1989) Anesthesiology , vol.70 , pp. 267-275
    • Tan, F.1    Jackman, H.2    Skidgel, R.A.3
  • 75
    • 0021683565 scopus 로고
    • Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization
    • Stewart WJ, McSweeney SM, Kellett MA, et al. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation 1984;5:788-792.
    • (1984) Circulation , vol.5 , pp. 788-792
    • Stewart, W.J.1    McSweeney, S.M.2    Kellett, M.A.3
  • 76
    • 0018181096 scopus 로고
    • Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody
    • Lakin JD, Blocker TJ, Strong DM, et al. Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody. J Allergy Clin Immunol 1978;61:102-107.
    • (1978) J Allergy Clin Immunol , vol.61 , pp. 102-107
    • Lakin, J.D.1    Blocker, T.J.2    Strong, D.M.3
  • 77
    • 0024548652 scopus 로고
    • Lessons from studying an infrequent event:adverse hemodynamic responses associated with protamine reversal of heparin anticoagulation
    • Lowenstein E. Lessons from studying an infrequent event:adverse hemodynamic responses associated with protamine reversal of heparin anticoagulation. J Cardiothorac Anesth 1989;3:99-107.
    • (1989) J Cardiothorac Anesth , vol.3 , pp. 99-107
    • Lowenstein, E.1
  • 78
    • 0023884860 scopus 로고
    • Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep
    • Morel DR, Lowenstein E, Nguyenduy T, et al. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Circ Res 1988;62:905-915.
    • (1988) Circ Res , vol.62 , pp. 905-915
    • Morel, D.R.1    Lowenstein, E.2    Nguyenduy, T.3
  • 79
    • 0025175070 scopus 로고
    • Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep
    • Montalescot G, Lowenstein E, Ogletree ML, et al. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 1990;82:1765-1777.
    • (1990) Circulation , vol.82 , pp. 1765-1777
    • Montalescot, G.1    Lowenstein, E.2    Ogletree, M.L.3
  • 80
    • 0025853273 scopus 로고
    • Protamine-heparin-induced pulmonary hypertension in pigs:effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation
    • Nuttall GA, Murray MJ, Bowie JW. Protamine-heparin-induced pulmonary hypertension in pigs:effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Anesthesiology 1991;74:1-145.
    • (1991) Anesthesiology , vol.74 , pp. 1-145
    • Nuttall, G.A.1    Murray, M.J.2    Bowie, J.W.3
  • 81
    • 0024537085 scopus 로고
    • Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs
    • Conzen PF, Habazettl H, Gutman R, et al. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs. Anesth Analg 1989;68:25-31.
    • (1989) Anesth Analg , vol.68 , pp. 25-31
    • Conzen, P.F.1    Habazettl, H.2    Gutman, R.3
  • 82
    • 0010623230 scopus 로고
    • Effect of thromboxane receptor antagonism on pulmonary hypertension caused by protamine-heparin interaction in pigs
    • Schumacher WA, Heran CL, Ogletree ML. Effect of thromboxane receptor antagonism on pulmonary hypertension caused by protamine-heparin interaction in pigs. Circulation 1988;78(Suppl):II-207.
    • (1988) Circulation , vol.78 , pp. 11-207
    • Schumacher, W.A.1    Heran, C.L.2    Ogletree, M.L.3
  • 83
    • 0023545228 scopus 로고
    • Pulmonary hypertensive effect of heparin and protamine interaction:evidence for thromboxane B2 release from the lung
    • Degges RD, Foster ME, Dang AQ, et al. Pulmonary hypertensive effect of heparin and protamine interaction:evidence for thromboxane B2 release from the lung. Am J Surg 1987;154:696-699.
    • (1987) Am J Surg , vol.154 , pp. 696-699
    • Degges, R.D.1    Foster, M.E.2    Dang, A.Q.3
  • 84
    • 0023024650 scopus 로고
    • Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonist
    • Friedhoff LT, Manning J, Funke PT, et al. Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonist. Clin Pharmacol Ther 1986;40:634-642.
    • (1986) Clin Pharmacol Ther , vol.40 , pp. 634-642
    • Friedhoff, L.T.1    Manning, J.2    Funke, P.T.3
  • 85
    • 0024407020 scopus 로고
    • Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions
    • Montalescot G, Kreil E, Lynch K, et al. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions. J Appl Physiol 1989;66:2344-2350.
    • (1989) J Appl Physiol , vol.66 , pp. 2344-2350
    • Montalescot, G.1    Kreil, E.2    Lynch, K.3
  • 86
    • 84970993355 scopus 로고
    • Adverse heparin-protamine neutralization interactions and the lung
    • In:Zapol WM, Lemarie F, eds. New York:Marcel Dekker Inc
    • Kreil E, Montalescot G, Robinson DR, et al. Adverse heparin-protamine neutralization interactions and the lung. In:Zapol WM, Lemarie F, eds. Adult respiratory distress sydrome. New York:Marcel Dekker Inc, 1991:451-490.
    • (1991) Adult respiratory distress sydrome. , pp. 451-490
    • Kreil, E.1    Montalescot, G.2    Robinson, D.R.3
  • 87
    • 0022506702 scopus 로고
    • Pulmonary intravascular macrophages in sheep:morphology and function of a novel constituent of the mononuclear phagocyte system
    • Warner AE, Barry BE, Brain JD. Pulmonary intravascular macrophages in sheep:morphology and function of a novel constituent of the mononuclear phagocyte system. Lab Invest 1986;55:276-288.
    • (1986) Lab Invest , vol.55 , pp. 276-288
    • Warner, A.E.1    Barry, B.E.2    Brain, J.D.3
  • 88
    • 0023748574 scopus 로고
    • Pulmonary intravascular macrophages metabolize arachidonic acid in vitro
    • Bertram TA, Overby LH, Danilowicz R, et al. Pulmonary intravascular macrophages metabolize arachidonic acid in vitro. Am Rev RespirDis 1988;1:936-944.
    • (1988) Am Rev RespirDis , vol.1 , pp. 936-944
    • Bertram, T.A.1    Overby, L.H.2    Danilowicz, R.3
  • 89
    • 0023803434 scopus 로고
    • Pulmonary removal of circulating endotoxin results in acute lung injury in sheep
    • Warner AE, DeCamp MM, Molina RM, et al. Pulmonary removal of circulating endotoxin results in acute lung injury in sheep. Lab Invest 1988;59:219-230.
    • (1988) Lab Invest , vol.59 , pp. 219-230
    • Warner, A.E.1    DeCamp, M.M.2    Molina, R.M.3
  • 90
    • 0023481289 scopus 로고
    • Uptake of blood-borne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep
    • Warner A, Molina A, Brain JD. Uptake of blood-borne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep. Am Rev RespirDis 1987;136:683-690.
    • (1987) Am Rev RespirDis , vol.136 , pp. 683-690
    • Warner, A.1    Molina, A.2    Brain, J.D.3
  • 91
    • 0019463651 scopus 로고
    • Bacteremia:host-specific lung clearance and pulmonary failure
    • Crocker SH, Eddy DO, Obenauf RN, et al. Bacteremia:host-specific lung clearance and pulmonary failure. J Trauma 1981;21:215-220.
    • (1981) J Trauma , vol.21 , pp. 215-220
    • Crocker, S.H.1    Eddy, D.O.2    Obenauf, R.N.3
  • 92
    • 24544475653 scopus 로고
    • Clearance of monastral blue by intravascular macrophages in pulmonary microvessels of sheep, goat, and pig
    • Albertine KH, Decker SA, Schultz EL, et al. Clearance of monastral blue by intravascular macrophages in pulmonary microvessels of sheep, goat, and pig. Anat Rec 1987;218:6A(abst).
    • (1987) Anat Rec , vol.218 , pp. 6A
    • Albertine, K.H.1    Decker, S.A.2    Schultz, E.L.3
  • 93
    • 84971000061 scopus 로고
    • Bacterial phagocytosis and consequent arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages in vitro
    • Bertram TA, Thigpen J, Eling TE, et al. Bacterial phagocytosis and consequent arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages in vitro. Am Rev Respir Dis 1989;139:A159.
    • (1989) Am Rev Respir Dis , vol.139 , pp. A159
    • Bertram, T.A.1    Thigpen, J.2    Eling, T.E.3
  • 94
    • 0025003992 scopus 로고
    • Adverse cardiopulmonary effects and increased thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent
    • Morel DR, Costabella PM, Pittet JF. Adverse cardiopulmonary effects and increased thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent. Anesthesiology 1990;73:415-424.
    • (1990) Anesthesiology , vol.73 , pp. 415-424
    • Morel, D.R.1    Costabella, P.M.2    Pittet, J.F.3
  • 95
    • 0022648525 scopus 로고
    • Hemodynamic changes after the administration of protamine
    • Casthely PA, Goodman K, Fryman PN, et al. Hemodynamic changes after the administration of protamine. Anesth Analg 1986;65:78-80.
    • (1986) Anesth Analg , vol.65 , pp. 78-80
    • Casthely, P.A.1    Goodman, K.2    Fryman, P.N.3
  • 96
    • 0022549839 scopus 로고
    • Comparison of the cardiovascular effects of intravenous and intraaortic protamine in the conscious and anesthetized dog
    • Taylor RL, Little WC, Freeman GL, et al. Comparison of the cardiovascular effects of intravenous and intraaortic protamine in the conscious and anesthetized dog. Ann Thorac Surg 1986;42:22-26.
    • (1986) Ann Thorac Surg , vol.42 , pp. 22-26
    • Taylor, R.L.1    Little, W.C.2    Freeman, G.L.3
  • 98
    • 0020613725 scopus 로고
    • The hemodynamic effects of intaaortic versus intravenous administration of protamine for reversal of heparin in man
    • Milne B, Rogers K, Cervenko F, et al. The hemodynamic effects of intaaortic versus intravenous administration of protamine for reversal of heparin in man. Can Anaesth Soc J 1983;30:347-351.
    • (1983) Can Anaesth Soc J , vol.30 , pp. 347-351
    • Milne, B.1    Rogers, K.2    Cervenko, F.3
  • 99
    • 0022352909 scopus 로고
    • Intraaortic vs. intravenous administration of protamine:a prospective randomized clinical study
    • Cherry DA, Chiu CJ, Wynands JE, et al. Intraaortic vs. intravenous administration of protamine:a prospective randomized clinical study. Surg Forum 1985;36:2-250.
    • (1985) Surg Forum , vol.36 , pp. 2-250
    • Cherry, D.A.1    Chiu, C.J.2    Wynands, J.E.3
  • 100
    • 0023262178 scopus 로고
    • C5a and thromboxane generation associated with pulmonary vaso-and bronchocon- striction during protamine reversal of heparin
    • Morel DR, Zapol WM, Thomas SJ, et al. C5a and thromboxane generation associated with pulmonary vaso-and bronchocon- striction during protamine reversal of heparin. Anesthesiology 1987;66:597-604.
    • (1987) Anesthesiology , vol.66 , pp. 597-604
    • Morel, D.R.1    Zapol, W.M.2    Thomas, S.J.3
  • 101
    • 0026052434 scopus 로고
    • Heparin reversal by protamine in humans-complement, prostaglandins, leukocytes, platelets, and hemodynamics
    • Hobbhahn J, Conzen P, Habazettl H, et al. Heparin reversal by protamine in humans-complement, prostaglandins, leukocytes, platelets, and hemodynamics. J Appl Physiol 1991;71:1415-1421.
    • (1991) J Appl Physiol , vol.71 , pp. 1415-1421
    • Hobbhahn, J.1    Conzen, P.2    Habazettl, H.3
  • 102
    • 0021243143 scopus 로고
    • Intradermal testing after anaphylactoid reaction to anaesthetic drugs:practical aspects of performance and interpretation
    • Fisher M. Intradermal testing after anaphylactoid reaction to anaesthetic drugs:practical aspects of performance and interpretation. Anaesth Intensive Care 1984;12:115-120.
    • (1984) Anaesth Intensive Care , vol.12 , pp. 115-120
    • Fisher, M.1
  • 103
    • 0014816727 scopus 로고
    • Procedures for immunochemical study of histamine release from leukocytes with small volumes of blood
    • May CD, Lyman M, Alberto R, et al. Procedures for immunochemical study of histamine release from leukocytes with small volumes of blood. J Allergy 1970;46:12-20.
    • (1970) J Allergy , vol.46 , pp. 12-20
    • May, C.D.1    Lyman, M.2    Alberto, R.3
  • 104
    • 0025087208 scopus 로고
    • Probable reversal of protamine reactions by heparin administration
    • Loch R, Hessel EA. Probable reversal of protamine reactions by heparin administration. J Cardiothorac Anesth 1990;4:604-608.
    • (1990) J Cardiothorac Anesth , vol.4 , pp. 604-608
    • Loch, R.1    Hessel, E.A.2
  • 105
    • 0026329105 scopus 로고
    • Inhaled nitric oxide. A selective pulmonary vasodilator of heparin protamine vasoconstriction in sheep
    • Fratacci MD, Frostell CG, Chen TY, et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin protamine vasoconstriction in sheep. Anesthesiology 1991;75:990-999.
    • (1991) Anesthesiology , vol.75 , pp. 990-999
    • Fratacci, M.D.1    Frostell, C.G.2    Chen, T.Y.3
  • 106
    • 0024438976 scopus 로고
    • Cardiopulmonary bypass without systemic heparinization
    • Von Segesser LK, Turina M. Cardiopulmonary bypass without systemic heparinization. J Thorac Cardiovasc Surg 1989;98:6-396.REFERENCES.
    • (1989) J Thorac Cardiovasc Surg , vol.98 , pp. 6-396
    • Von Segesser, L.K.1    Turina, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.